GO:0060065 uterus development: Morphogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060065 (uterus development) describes the reproductive developmental process by which the uterus progresses from formation to the mature structure, also known as Müllerian tract development.
• Human uterine morphogenesis begins with Müllerian duct formation and fusion, followed by septal resorption, myometrial and endometrial differentiation, and glandular maturation that continues into puberty.
• Estrogen receptor alpha (ESR1) directly binds estrogen-responsive elements to regulate Igf1 transcription and drive uterine growth, establishing a key hormonal control node.
• Uterine gland development is regulated by progesterone, which inhibits gland formation in the neonatal mouse uterus, and by carbonic anhydrase activity.
• Disrupted uterus development underlies Müllerian anomalies such as septate, bicornuate, and unicornuate uterus, which are associated with infertility and pregnancy complications.
• CRISPR-based knockout, knock-in, and overexpression models in mice and other species enable causal dissection of genes controlling uterine morphogenesis and gland development.
Description
Uterus development (GO:0060065) is the reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure. This process encompasses the specification, elongation, and fusion of the Müllerian ducts, the resorption of the midline septum, the differentiation of the endometrium and myometrium, and the postnatal maturation of uterine glands. Because the uterus is essential for implantation and pregnancy, defects in its development are a major cause of infertility and obstetric complications in humans. Understanding the molecular and cellular mechanisms that govern uterus development is therefore of direct clinical and biological importance. Research into uterus development spans classical embryology, hormonal signaling, and modern genetic approaches. The process is orchestrated by a combination of transcription factors, growth factors, and steroid hormones, with estrogen and progesterone acting as critical regulators of uterine growth and gland formation. Animal models, particularly mice and domestic species, have provided much of the mechanistic insight into how the uterus forms and matures. More recently, bioengineering approaches such as decellularized uterus scaffolds have been explored to reconstruct uterine tissue, highlighting the translational relevance of understanding normal uterine development. For researchers, GO:0060065 provides a structured framework to annotate genes and pathways involved in uterine morphogenesis and maturation. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to describe the definition, stages, key genes, disease links, and experimental methods relevant to uterus development.
uterus development At A Glance
| GO ID | GO:0060065 |
|---|---|
| GO term | uterus development |
| Ontology | biological_process |
| Synonym | Mullerian tract development |
| Definition | The reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure. |
| Major function | Formation and maturation of the uterus, including Müllerian duct morphogenesis, endometrial and myometrial differentiation, and uterine gland development. |
| Key regulators | ESR1, IGF1, progesterone signaling, carbonic anhydrase, and CXCL15-expressing cell lineages. |
| Related anomalies | Müllerian anomalies such as septate, bicornuate, and unicornuate uterus. |
| Research models | Mouse, rat, and domestic animal models; decellularized uterus scaffolds for tissue engineering. |
What Is GO:0060065?
GO:0060065 (uterus development) is defined as the reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure. It is synonymous with Müllerian tract development, reflecting the embryonic origin of the uterus from the Müllerian ducts. This biological process includes the morphological and cellular events that build the uterus, such as duct elongation and fusion, septal regression, tissue differentiation, and glandular maturation, and it continues postnatally until the uterus reaches its mature functional state.
Why Is uterus development Important in Cell Biology?
Uterus development is fundamental to female reproductive health because the uterus is the organ where embryo implantation and fetal development occur. Disruptions in this process lead to congenital Müllerian anomalies that are associated with infertility, recurrent pregnancy loss, and preterm birth. Understanding the hormonal and genetic control of uterine growth and gland development also informs strategies for treating uterine factor infertility and for engineering uterine tissue. Moreover, because uterine development continues postnatally and is sensitive to steroid hormones, it provides a tractable system to study how endocrine signals shape organ morphogenesis.
• Uterus development is required for establishment of a functional uterus capable of supporting implantation and pregnancy.
• Müllerian duct anomalies arising from defective development are linked to infertility and adverse pregnancy outcomes.
• Estrogen receptor alpha directly regulates Igf1 transcription to control uterine growth, linking hormonal signaling to developmental gene expression.
• Progesterone signaling inhibits neonatal uterine gland development, demonstrating stage-specific hormonal control.
• Carbonic anhydrase activity is necessary for endometrial gland development in the neonatal uterus.
• Uterine glands are essential for conceptus survival and are a focus of research in domestic animals and humans.
• Bioengineered uterus approaches rely on knowledge of normal uterine extracellular matrix and cellular composition.
• Cre recombinase models such as Cxcl15-Cre enable lineage-specific study of uterine gland development.
• Defects in uterine development can be modeled in mice to identify causal genes and pathways.
• Understanding uterus development supports development of diagnostics and therapies for uterine factor infertility.
What Happens During uterus development?
Müllerian duct formation and elongation
In simple terms: The uterus starts as two tubes that grow and later fuse.
In the human embryo, the uterus develops from the paired Müllerian ducts, which arise from the coelomic epithelium and elongate caudally. These ducts are the anlagen of the female reproductive tract, and their proper formation is the first step in uterus development. Disruptions at this stage can lead to agenesis or hypoplasia of the uterus.
Fusion and septal resorption
In simple terms: The two tubes merge, and the wall between them disappears to create a single cavity.
After elongation, the Müllerian ducts fuse at the midline to form the uterovaginal canal, and the intervening septum is subsequently resorbed to create a single uterine cavity. Failure of fusion or resorption results in Müllerian anomalies such as bicornuate or septate uterus. This stage is a critical determinant of uterine shape and cavity architecture.
Myometrial and endometrial differentiation
In simple terms: The uterine wall develops distinct muscle and lining layers.
Following fusion, the uterine mesenchyme differentiates into the myometrium and endometrium, establishing the layered structure of the mature uterus. This differentiation is regulated by local signaling and hormonal cues, and it sets the stage for cyclic remodeling in adulthood. Estrogen signaling through ESR1 contributes to uterine growth during these developmental transitions.
Postnatal uterine growth and gland development
In simple terms: After birth, the uterus grows and develops glands under hormonal control.
Uterus development continues postnatally, with significant growth and maturation occurring before menarche. Uterine gland development, in particular, is a postnatal process that is regulated by steroid hormones; progesterone inhibits gland development in the neonatal mouse uterus, while carbonic anhydrase activity is required for endometrial gland development. In domestic animals, uterine glands are essential for conceptus survival and are a major focus of reproductive biology. Lineage-tracing tools such as Cxcl15-Cre mice have been developed to study gland development in the uterus.
Hormonal regulation of uterine growth
In simple terms: Estrogen and progesterone control how the uterus grows and matures.
Estrogen and progesterone are central regulators of uterine development and growth. Estrogen receptor alpha (ESR1) binds directly to estrogen-responsive elements to regulate Igf1 transcription, which in turn promotes uterine growth. Progesterone signaling modulates gland development in a stage-specific manner, inhibiting gland formation in the neonatal uterus. These hormonal pathways integrate with local growth factors to coordinate uterine morphogenesis.
Key Genes Involved in GO:0060065 uterus development
The following genes and proteins have been implicated in uterus development, uterine growth, or uterine gland formation based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESR1 | Estrogen receptor alpha; mediates estrogen-dependent uterine growth by binding estrogen-responsive elements and regulating Igf1 transcription. | Key regulator of uterine growth; knockout models show impaired uterine development and function. |
| IGF1 | Insulin-like growth factor 1; downstream target of ESR1 that promotes uterine growth. | Mediates estrogen-driven uterine proliferation; useful for studying growth factor signaling in uterus development. |
| PGR | Progesterone receptor; mediates progesterone signaling that inhibits neonatal uterine gland development. | Critical for understanding hormonal control of gland development; knockout models display glandular defects. |
| CA2 | Carbonic anhydrase 2; enzyme required for endometrial gland development in the neonatal uterus. | Provides insight into pH regulation and gland morphogenesis; knockout or inhibitor studies are informative. |
| CXCL15 | Chemokine expressed in uterine gland epithelium; used as a marker for gland development. | Cxcl15-Cre mouse model enables lineage tracing of gland development. |
| WNT4 | Wnt family member 4; involved in Müllerian duct formation and uterine patterning. | Mutations are associated with Müllerian anomalies; useful for developmental studies. |
| WNT7A | Wnt family member 7A; regulates Müllerian duct and uterine development. | Loss-of-function leads to uterine malformations; relevant for congenital anomaly research. |
| HOXA10 | Homeobox A10; transcription factor important for uterine differentiation and implantation. | Key marker of endometrial receptivity; knockout models show uterine defects. |
| HOXA11 | Homeobox A11; required for uterine development and gland formation. | Mutations linked to uterine anomalies; useful for developmental genetics. |
| LHX1 | LIM homeobox 1; transcription factor involved in Müllerian duct epithelium differentiation. | Essential for female reproductive tract development; knockout models show uterine agenesis. |
| PAX2 | Paired box 2; regulates Müllerian duct elongation and epithelial differentiation. | Haploinsufficiency causes renal and Müllerian anomalies; relevant for developmental studies. |
| EMX2 | Empty spiracles homeobox 2; involved in uterine epithelial development. | Knockout mice exhibit uterine hypoplasia; useful for epithelial-mesenchymal interaction studies. |
| DKK1 | Dickkopf WNT signaling pathway inhibitor 1; modulates Wnt signaling during uterine development. | Potential regulator of Müllerian duct patterning; useful for pathway dissection. |
| CTNNB1 | Beta-catenin; mediates Wnt signaling in uterine mesenchyme and epithelium. | Conditional knockout models reveal roles in uterine differentiation. |
| AMHR2 | Anti-Müllerian hormone receptor type 2; mediates AMH signaling that regresses Müllerian ducts in males. | Relevant for understanding sex-specific reproductive tract development. |
| SRY | Sex-determining region Y; initiates male differentiation and indirectly affects Müllerian duct regression. | Important for studying sexual dimorphism in reproductive tract development. |
| Cxcl15 | Chemokine used as a marker for uterine gland epithelium in mice. | Enables Cre-mediated lineage tracing of gland development. |
How Is uterus development Regulated?
Uterus development is regulated by a complex interplay of hormonal and local signaling pathways. Estrogen, acting through ESR1, directly regulates Igf1 transcription to promote uterine growth. Progesterone signaling, via the progesterone receptor, inhibits uterine gland development in the neonatal mouse uterus, demonstrating stage-specific negative regulation. Carbonic anhydrase activity is required for endometrial gland development, linking pH regulation to gland morphogenesis. In domestic animals, uterine gland development and function are controlled by ovarian steroids and local growth factors, and glands are essential for conceptus survival. Additionally, Wnt signaling and homeobox transcription factors such as HOXA10, HOXA11, and LHX1 are critical for Müllerian duct patterning and uterine differentiation.
uterus development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WNT4 | Müllerian anomalies, including Mayer-Rokitansky-Küster-Hauser syndrome | Wnt4 knockout mouse; knock-in of patient variants |
| HOXA10 | Uterine hypoplasia and implantation failure | Hoxa10 knockout mouse; overexpression in uterine epithelial cells |
| HOXA11 | Uterine anomalies and infertility | Hoxa11 knockout mouse; conditional knock-in |
| PGR | Defective uterine gland development and implantation defects | Pgr knockout mouse; progesterone antagonist treatment |
| ESR1 | Impaired uterine growth and infertility | Esr1 knockout mouse; tissue-specific knockout |
Müllerian anomalies and infertility
Congenital anomalies of the uterus, including septate, bicornuate, unicornuate, and didelphys uterus, arise from defects in Müllerian duct development, fusion, or septal resorption. These anomalies are associated with infertility, recurrent pregnancy loss, and obstetric complications. Understanding the genetic and environmental causes of these malformations is essential for diagnosis and clinical management.
Uterine gland dysfunction and implantation failure
Uterine glands are critical for implantation and conceptus survival, and their development is regulated by progesterone and carbonic anhydrase. Disrupted gland development can lead to implantation failure and pregnancy loss in animal models and is thought to contribute to uterine factor infertility in humans. Research into the molecular control of gland development may inform new therapeutic strategies.
Developmental origins of uterine disease
Alterations in uterine development, including hormonal exposure during critical windows, can program lasting changes in uterine function and may predispose to conditions such as endometriosis or adenomyosis, although direct causal links require further study. Animal models with targeted mutations in genes such as ESR1, PGR, and HOXA10 provide mechanistic insights into how developmental defects contribute to adult uterine pathology.
From uterus development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene drive uterine gland development? | Knockout mouse (e.g., Cxcl15-Cre for lineage tracing) |
| How does a specific point mutation affect uterine morphogenesis? | Point-mutation knock-in mouse via CRISPR |
| What is the effect of overexpressing a growth factor on uterine growth? | Transgenic overexpression mouse |
| Can a human variant cause Müllerian anomalies? | Knock-in of human variant in mouse |
| How does hormonal signaling regulate uterine gene expression? | Hormone-treated ovariectomized mouse models |
| Can decellularized scaffolds support uterine regeneration? | Rat uterus decellularization and recellularization |
How to Study the uterus development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cre-lox lineage tracing | Cell fate and origin of uterine cell types | Studying gland development using Cxcl15-Cre |
| RNA-seq | Transcriptional changes during uterus development | Identifying hormone-responsive genes |
| ChIP-seq | Direct binding of transcription factors to DNA | Mapping ESR1 binding to estrogen-responsive elements |
| Immunohistochemistry | Protein localization and tissue architecture | Assessing gland and epithelial markers |
| Decellularization/recellularization | Extracellular matrix composition and regenerative capacity | Bioengineering uterine tissue |
| Hormone treatment | Effects of estrogen/progesterone on uterine growth | Neonatal or ovariectomized mouse models |
| In situ hybridization | Spatial gene expression patterns | Localizing Wnt and Hox gene transcripts |
| CRISPR genome editing | Gene function via knockout or knock-in | Testing candidate genes in mouse models |
Lineage tracing and Cre-lox models
Cre recombinase models, such as Cxcl15-Cre mice, allow selective labeling of uterine gland epithelium to study its development and differentiation. These tools are essential for understanding the cellular origins of uterine compartments and for tracking cell fate during morphogenesis.
Hormonal manipulation and gene expression analysis
Treating neonatal or ovariectomized mice with estrogen or progesterone, followed by RNA analysis of uterine tissue, reveals hormone-responsive gene networks. Chromatin immunoprecipitation can identify direct targets such as Igf1 that are regulated by ESR1 binding to estrogen-responsive elements.
Histology and immunohistochemistry
Tissue sectioning and staining for markers of epithelium, stroma, and myometrium are used to assess uterine morphology and gland development. Carbonic anhydrase activity can be visualized to study its role in gland development.
Tissue engineering and decellularization
Decellularization protocols applied to rat uterus provide scaffolds that can be recellularized to study uterine regeneration and development in vitro. These approaches complement genetic models by testing the role of extracellular matrix in uterine morphogenesis.
How CRISPR Can Be Used to Study GO:0060065 uterus development
Knockout
CRISPR knockout of genes such as Esr1, Pgr, or Hoxa10 in mice can reveal their essential roles in uterus development, including effects on uterine growth, gland formation, and fertility. Knockout models are foundational for establishing causality between a gene and a developmental phenotype.
Point Mutation
Introducing precise point mutations that mimic human variants, for example in WNT4 or HOXA11, allows researchers to test whether specific amino acid changes disrupt uterine morphogenesis. These models are valuable for understanding the molecular basis of Müllerian anomalies.
Knock-in
Knock-in of reporter genes or human disease alleles into the mouse genome enables visualization of gene expression and functional analysis of variants in uterus development. For example, knocking in a Cre recombinase into the Cxcl15 locus facilitates lineage tracing of uterine glands.
Overexpression
CRISPR-mediated overexpression or transgenic insertion of growth factors such as Igf1 can be used to study their effects on uterine growth and gland development. Overexpression models help determine whether increased signaling is sufficient to drive developmental changes.
How EDITGENE Supports uterus development Research
Researchers studying uterus development-related genes often need to determine whether a candidate gene is causally involved in uterine morphogenesis, gland formation, or hormonal response. Establishing causality requires precise genetic manipulation in relevant models, and CRISPR-based approaches provide the necessary tools to generate knockout, point-mutation, knock-in, and overexpression cell and animal models.
Contact EDITGENE today to design your custom CRISPR model for uterus development research.
Frequently Asked Questions About uterus development
What is GO:0060065?
GO:0060065 is the Gene Ontology term for uterus development, defined as the reproductive developmental process whose specific outcome is the progression of the uterus over time, from its formation to the mature structure.
What genes are involved in uterus development?
Key genes include ESR1, IGF1, PGR, WNT4, WNT7A, HOXA10, HOXA11, LHX1, PAX2, and EMX2, among others.
What are Müllerian anomalies?
Müllerian anomalies are congenital defects of the uterus and female reproductive tract caused by abnormal development, fusion, or septal resorption of the Müllerian ducts, leading to conditions such as septate or bicornuate uterus.
How is uterus development regulated by hormones?
Estrogen, via ESR1, promotes uterine growth by regulating genes like Igf1, while progesterone inhibits neonatal uterine gland development.
What is the role of uterine glands in development?
Uterine glands are essential for implantation and conceptus survival, and their development is regulated by progesterone and carbonic anhydrase.
Which animal models are used to study uterus development?
Mice, rats, and domestic animals are commonly used; Cre-lox models such as Cxcl15-Cre enable lineage tracing of gland development.
How can CRISPR be used to study uterus development?
CRISPR can create knockout, point-mutation, knock-in, and overexpression models to test gene function in uterine morphogenesis and gland formation.
What is the connection between uterus development and infertility?
Defects in uterus development, such as Müllerian anomalies, are associated with infertility, recurrent pregnancy loss, and obstetric complications.
What is the role of carbonic anhydrase in uterine gland development?
Carbonic anhydrase activity is required for endometrial gland development in the neonatal uterus.
Can uterus development be studied in vitro?
Yes, decellularized uterus scaffolds and primary uterine cell cultures can be used to study aspects of uterine development and regeneration.
Conclusion
Uterus development (GO:0060065) is a complex biological process that transforms the Müllerian ducts into a mature, functional uterus capable of supporting pregnancy. It is regulated by hormonal signals, transcription factors, and local growth factors, with estrogen and progesterone playing central roles. Defects in this process cause Müllerian anomalies and contribute to infertility, making it a critical area of reproductive biology research. Advances in CRISPR genome editing and bioengineering now provide powerful tools to dissect the genetic and cellular mechanisms of uterus development and to develop new therapeutic strategies.
References
- 1. Habiba M et al.. 2021. The development of the human uterus: morphogenesis to menarche.. Hum Reprod Update 27(1):1-26 PMID: 33395479
- 2. Kelleher AM et al.. 2025. A Cxcl15 Cre Recombinase Mouse Model Useful to Study Gland Development in the Uterus.. Genesis 63(5):e70026 PMID: 40888633
- 3. Hellström M et al.. 2014. Towards the development of a bioengineered uterus: comparison of different protocols for rat uterus decellularization.. Acta Biomater 10(12):5034-5042 PMID: 25169258
- 4. Hewitt SC et al.. 2010. Estrogen-mediated regulation of Igf1 transcription and uterine growth involves direct binding of estrogen receptor alpha to estrogen-responsive elements.. J Biol Chem 285(4):2676-85 PMID: 19920132
- 5. Hu J et al.. 2005. Carbonic anhydrase regulate endometrial gland development in the neonatal uterus.. Biol Reprod 73(1):131-8 PMID: 15788756
- 6. Spencer TE et al.. 2019. Development and Function of Uterine Glands in Domestic Animals.. Annu Rev Anim Biosci 7:125-147 PMID: 30183326
- 7. Gell JS. 2003. Müllerian anomalies.. Semin Reprod Med 21(4):375-88 PMID: 14724770
- 8. Filant J et al.. 2012. Progesterone inhibits uterine gland development in the neonatal mouse uterus.. Biol Reprod 86(5):146, 1-9 PMID: 22238285
